Shenghua Yang

1.1k total citations
25 papers, 536 citations indexed

About

Shenghua Yang is a scholar working on Molecular Biology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Shenghua Yang has authored 25 papers receiving a total of 536 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Surgery and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Shenghua Yang's work include Lipoproteins and Cardiovascular Health (4 papers), MicroRNA in disease regulation (3 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers). Shenghua Yang is often cited by papers focused on Lipoproteins and Cardiovascular Health (4 papers), MicroRNA in disease regulation (3 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers). Shenghua Yang collaborates with scholars based in China, Taiwan and Indonesia. Shenghua Yang's co-authors include Jian‐Jun Li, Hao Xu, Zhuo Chen, Cheng‐Gang Zhu, Rui‐Xia Xu, Sha Li, Na‐Qiong Wu, Ying Du, Huimin Guo and Shaoru Li and has published in prestigious journals such as Scientific Reports, Construction and Building Materials and European Journal of Pharmacology.

In The Last Decade

Shenghua Yang

24 papers receiving 528 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shenghua Yang China 14 190 138 123 98 84 25 536
Junna Yamaguchi Japan 11 213 1.1× 97 0.7× 95 0.8× 136 1.4× 43 0.5× 16 620
Leena E. Viiri Finland 16 225 1.2× 144 1.0× 100 0.8× 69 0.7× 143 1.7× 30 574
Iwona Żak Poland 16 133 0.7× 135 1.0× 64 0.5× 90 0.9× 144 1.7× 56 593
Jiangtao Yan China 12 159 0.8× 66 0.5× 64 0.5× 80 0.8× 90 1.1× 23 460
Eddy S. Konaniah United States 13 273 1.4× 166 1.2× 64 0.5× 115 1.2× 151 1.8× 17 752
Paul Robillard France 15 173 0.9× 268 1.9× 108 0.9× 179 1.8× 103 1.2× 23 603
Hajime Nakaoka Japan 13 190 1.0× 173 1.3× 89 0.7× 132 1.3× 138 1.6× 29 571
Qian Yu China 13 269 1.4× 56 0.4× 126 1.0× 105 1.1× 25 0.3× 45 557
Emanuela Lapice Italy 10 367 1.9× 90 0.7× 85 0.7× 139 1.4× 52 0.6× 15 634
Stefan Seibold Germany 13 252 1.3× 81 0.6× 93 0.8× 49 0.5× 103 1.2× 17 632

Countries citing papers authored by Shenghua Yang

Since Specialization
Citations

This map shows the geographic impact of Shenghua Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shenghua Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shenghua Yang more than expected).

Fields of papers citing papers by Shenghua Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shenghua Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shenghua Yang. The network helps show where Shenghua Yang may publish in the future.

Co-authorship network of co-authors of Shenghua Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Shenghua Yang. A scholar is included among the top collaborators of Shenghua Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shenghua Yang. Shenghua Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zeng, Yao, et al.. (2025). Lipoic acid coated AgNPs incorporating with hydrogel for synergistic photodynamic/Ag+ bactericidal. Materials Today Communications. 44. 112023–112023. 2 indexed citations
2.
Lin, Xiang, Jie Luo, Shenghua Yang, et al.. (2025). All-biomass phosphorylated cellulose/gelatin composite aerogel with excellent mechanical and flame-retardant properties. Construction and Building Materials. 501. 144291–144291.
3.
Wu, Pei‐Yi, et al.. (2024). Enhancing cisplatin efficacy in hepatocellular carcinoma with selenocystine: The suppression of DNA repair and inhibition of proliferation in hepatoma cells. Chemico-Biological Interactions. 405. 111291–111291. 2 indexed citations
4.
Meng, Shuai, Xiangyun Kong, Jing Nan, et al.. (2023). Comparing the clinical outcomes of single vs. systematic dual stenting strategies for unprotected left main bifurcation lesion: a systematic review and meta-analysis. Frontiers in Cardiovascular Medicine. 10. 1145412–1145412. 1 indexed citations
5.
Zhou, Jian, Qiang Fu, Xiaowei Xu, et al.. (2022). The associations between TMAO-related metabolites and blood lipids and the potential impact of rosuvastatin therapy. Lipids in Health and Disease. 21(1). 60–60. 27 indexed citations
6.
Luo, Yueh-Hsia, et al.. (2022). Selenocystine induces oxidative-mediated DNA damage via impairing homologous recombination repair of DNA double-strand breaks in human hepatoma cells. Chemico-Biological Interactions. 365. 110046–110046. 10 indexed citations
7.
Wang, Shuhua, Yuanyuan Wu, Shenghua Yang, et al.. (2020). miR‐874 directly targets AQP3 to inhibit cell proliferation, mobility and EMT in non‐small cell lung cancer. Thoracic Cancer. 11(6). 1550–1558. 23 indexed citations
8.
Wang, Shuhua, Fengxia Liu, Hui Ma, et al.. (2020). circCDYL Acts as a Tumor Suppressor in Triple Negative Breast Cancer by Sponging miR-190a-3p and Upregulating TP53INP1. Clinical Breast Cancer. 20(5). 422–430. 32 indexed citations
9.
Yang, Shenghua, Rui‐Xia Xu, Chuan-Jue Cui, et al.. (2018). Liraglutide downregulates hepatic LDL receptor and PCSK9 expression in HepG2 cells and db/db mice through a HNF-1a dependent mechanism. Cardiovascular Diabetology. 17(1). 48–48. 43 indexed citations
10.
Guo, Huimin, et al.. (2018). LncRNA SNHG20 promotes cell proliferation and invasion via miR-140-5p-ADAM10 axis in cervical cancer. Biomedicine & Pharmacotherapy. 102. 749–757. 70 indexed citations
11.
Yang, Shenghua, Ying Du, Yan Zhang, et al.. (2017). Serum fibrinogen and cardiovascular events in Chinese patients with type 2 diabetes and stable coronary artery disease: a prospective observational study. BMJ Open. 7(6). e015041–e015041. 23 indexed citations
12.
13.
Yang, Shenghua, Xiaolin Li, Yan Zhang, et al.. (2017). Triglyceride to High-Density Lipoprotein Cholesterol Ratio and Cardiovascular Events in Diabetics With Coronary Artery Disease. The American Journal of the Medical Sciences. 354(2). 117–124. 47 indexed citations
14.
Du, Ying, Sha Li, Chuan-Jue Cui, et al.. (2016). Leptin decreases the expression of low-density lipoprotein receptor via PCSK9 pathway: linking dyslipidemia with obesity. Journal of Translational Medicine. 14(1). 276–276. 28 indexed citations
15.
16.
Chen, Zhuo, Shenghua Yang, Hao Xu, & Jian‐Jun Li. (2016). ABO blood group system and the coronary artery disease: an updated systematic review and meta-analysis. Scientific Reports. 6(1). 23250–23250. 81 indexed citations
17.
Yang, Shenghua, Ying Du, Sha Li, et al.. (2016). Plasma PCSK9 level is unrelated to blood pressure and not associated independently with carotid intima–media thickness in hypertensives. Hypertension Research. 39(8). 598–605. 16 indexed citations
18.
Yang, Shenghua, Sha Li, Yan Zhang, et al.. (2015). Positive correlation of plasma PCSK9 levels with HbA1c in patients with type 2 diabetes. Diabetes/Metabolism Research and Reviews. 32(2). 193–199. 36 indexed citations
19.
Hu, Xiaobo, Chi Zhang, Shenghua Yang, et al.. (2014). Piromelatine, a novel melatonin receptor agonist, stabilizes metabolic profiles and ameliorates insulin resistance in chronic sleep restricted rats. European Journal of Pharmacology. 727. 60–65. 29 indexed citations
20.
Yang, Shenghua, et al.. (2013). Oxidized low-density lipoprotein-induced CD147 expression and its inhibition by high-density lipoprotein on platelets in vitro. Thrombosis Research. 132(6). 702–711. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Junna Yamaguchi Breakdown of academic impact, for papers by Leena E. Viiri Breakdown of academic impact, for papers by Iwona Żak Breakdown of academic impact, for papers by Jiangtao Yan Breakdown of academic impact, for papers by Eddy S. Konaniah Breakdown of academic impact, for papers by Paul Robillard Breakdown of academic impact, for papers by Hajime Nakaoka Breakdown of academic impact, for papers by Qian Yu Breakdown of academic impact, for papers by Emanuela Lapice Breakdown of academic impact, for papers by Stefan Seibold
Rankless by CCL
2026